Solid Biosciences
SLDB
66 hedge funds and large institutions have $79.1M invested in Solid Biosciences in 2020 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 21 reducing their positions, and 16 closing their positions.
68% more capital invested
Capital invested by funds: $46.9M → $79.1M (+$32.1M)
1.03% more ownership
Funds ownership: 2.84% → 3.88% (+1%)
5% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 21
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more call options, than puts
Call options by funds: $182K | Put options by funds: $182K
7% less funds holding
Funds holding: 71 → 66 (-5)
31% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$18.7M |
| 2 |
EP
Eversept Partners
New York
|
+$1.13M |
| 3 |
BlackRock
New York
|
+$1.09M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$689K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$231K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$683K |
| 2 |
Millennium Management
New York
|
-$569K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$327K |
| 4 |
JP Morgan Chase
New York
|
-$226K |
| 5 |
SIM
Spark Investment Management
New York
|
-$188K |
SLDB Hedge Fund Activity: Q2 2020 in Review
66 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Solid Biosciences (SLDB) for Q2 2020, worth a combined $79.1M — up 68% from $46.9M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of SLDB and 11 opened new positions — a net loss of 5 holders — while 21 trimmed existing stakes and 22 added.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $18.7M. The largest seller was Susquehanna International Group, cutting an estimated $683K.
- 66 institutional investors held Solid Biosciences (SLDB) as of Q2 2020, down from 71 in Q1 2020.
- Funds reported $79.1M of Solid Biosciences stock for Q2 2020, up 68% quarter-over-quarter.
- 11 funds opened new Solid Biosciences positions in Q2 2020 and 16 closed out, a net change of -5 holders.
- The largest Solid Biosciences buyer in Q2 2020 was Perceptive Advisors, an estimated $18.7M added.
- The largest Solid Biosciences seller in Q2 2020 was Susquehanna International Group, an estimated $683K sold.
Based on aggregated 13F filings for Q2 2020.